Literature DB >> 9603383

Etiology of immune stromal (interstitial) keratitis.

G S Schwartz1, A R Harrison, E J Holland.   

Abstract

PURPOSE: We compared the etiologies of immune stromal keratitis (ISK), also known as interstitial keratitis (IK), in a recent group of patients with active and inactive ISK.
METHODS: We reviewed the charts of 97 patients seen in the cornea clinic at the University of Minnesota from 1985 through 1994. Fifty-five patients were classified as having active ISK, defined by stromal inflammation without ulceration within 1 year of presentation. Forty-two patients were identified as having inactive ISK, defined by evidence of past stromal inflammation including stromal scarring, stromal thinning, ghost vessels, and reduplication of Descemet's membrane without active inflammation for the 1 year before presentation. We determined the etiology of the ISK by careful review of the patient's ocular examination, as well as medical and laboratory workup. Patients were labeled with the diagnosis of idiopathic ISK if no identifiable etiology was found.
RESULTS: Herpes simplex virus (HSV) accounted for 71.4% of unilateral active ISK. Idiopathic accounted for 14.3%, and varicella-zoster virus accounted for 8.6% in this group. HSV was the etiologic factor of 50.0% of inactive unilateral cases, whereas 33.3% were idiopathic. Sixty percent of cases of bilateral, active ISK were from idiopathic causes. Syphilis was the cause of 48.5% of bilateral inactive cases. In this group, 33.3% were from idiopathic causes.
CONCLUSION: Although syphilis has been recognized for many years as the cause of 90% of cases of ISK, this is no longer true. We demonstrated that active ISK is most commonly caused by HSV or is idiopathic and that, although syphilis is the leading cause of inactive, bilateral ISK, it is responsible for only 18.6% of total cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603383

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Immune recovery disease: a case of interstitial keratitis and tonic pupil following bone marrow transplantation.

Authors:  A S Ioannidis; M Forrest; K K Nischal; P Veys; E G Davies; G Woodruff
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 2.  [Lues - Ocular syphilis].

Authors:  T Neß
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

3.  Specific antibody production in herpes keratitis: intraocular inflammation and corneal neovascularisation as predicting factors.

Authors:  Pierre-Yves Robert; Anja Liekfeld; Sylvia Metzner; Sylvie Ranger-Rogez; Jean-Paul Adenis; François Denis; Christian Hartmann; Uwe Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-26       Impact factor: 3.117

4.  Ocular manifestations of syphilis: recent cases over a 2.5-year period.

Authors:  Cindy Puech; Stéphane Gennai; Patricia Pavese; Isabelle Pelloux; Max Maurin; Jean-Paul Romanet; Christophe Chiquet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-12       Impact factor: 3.535

5.  Clinical and corneal microbial profile of infectious keratitis in a high HIV prevalence setting in rural South Africa.

Authors:  E Schaftenaar; R P H Peters; G S Baarsma; C Meenken; N S Khosa; S Getu; J A McIntyre; A D M E Osterhaus; G M G M Verjans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-28       Impact factor: 3.267

6.  In vivo corneal neovascularization imaging by optical-resolution photoacoustic microscopy.

Authors:  Wenzhong Liu; Kathryn M Schultz; Kevin Zhang; Amy Sasman; Fengli Gao; Tsutomu Kume; Hao F Zhang
Journal:  Photoacoustics       Date:  2014-06-01

7.  Bilateral interstitial keratitis, erythema nodosum and atrial fibrillation as presenting signs of polyarteritis nodosa.

Authors:  Filippos Vingopoulos; Theodoros Karagiotis; Sotiria Palioura
Journal:  Am J Ophthalmol Case Rep       Date:  2020-02-21

Review 8.  Adoption of Innovation in Herpes Simplex Virus Keratitis.

Authors:  James Chodosh; Lawson Ung
Journal:  Cornea       Date:  2020-11       Impact factor: 3.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.